A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years of Age
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2018
At a glance
- Drugs PXVX 0200 (Primary)
- Indications Cholera
- Focus Pharmacodynamics
- Sponsors PaxVax
- 07 Feb 2018 Planned number of patients changed from 525 to 595.
- 21 Jul 2017 Status changed from not yet recruiting to recruiting.
- 20 Jul 2017 New trial record